Contribution of the Rate of Change of Antimüllerian Hormone in Estimating Time to Menopause for Late Reproductive-age Women

Overview

Journal Fertil Steril

Specialty Reproductive Medicine

Date 2012 Aug 28

PMID 22921911

Citations 44

Authors

Ellen W Freeman

Mary D Sammel

Hui Lin

David W Boorman

Clarisa R Gracia

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the rate of change of antimüllerian hormone (AMH) level in the late reproductive years and its associations with time to menopause (TTM). We hypothesized that the rate of change between two measures of AMH reflects follicular atresia and varies among women independent of age.

Design: A14-year follow-up.

Setting: A randomly identified, population-based cohort (Penn Ovarian Aging Study).

Patient(s): Two measures of AMH were evaluated in survival analysis of 293 women.

Intervention(s): None.

Main Outcome Measure(s): Time to menopause.

Result(s): The rate of AMH change was a strong independent predictor of TTM in multivariable analysis after adjusting for AMH baseline, age, and smoking (hazard ratio for 1 SD change = 1.82, 95% confidence interval 1.56-2.14). Among women with similar AMH levels, TTM differed by approximately 2 years when compared between a slow and fast rate of AMH change. A significant interaction of AMH rate of change and age indicated that a faster decrease in AMH level was associated with an increased risk of menopause in women aged 35-39 years (hazard ratio 6.97, 95% confidence interval 3.81-12.72), with less dramatic but significant associations in women aged 40-44 and 45-48 years.

Conclusion(s): The AMH rate of change was independently associated with TTM in late reproductive-age women and increased the precision of estimates of TTM when included with an AMH baseline level and age. The rate of AMH change may be a more direct surrogate than age and increases the precision of estimates of TTM during this clinically important time period.

Citing Articles

The histological investigation of the effects of electromagnetic radiation on rat ovaries.

Kartal B, Alimogullari E, Akkurt G, Alimogullari M, Cayli S J Mol Histol. 2024; 56(1):29.

PMID: 39630206 DOI: 10.1007/s10735-024-10319-w.

Anti-Müllerian hormone: biology and role in endocrinology and cancers.

Gowkielewicz M, Lipka A, Zdanowski W, Wasniewski T, Majewska M, Carlberg C Front Endocrinol (Lausanne). 2024; 15:1468364.

PMID: 39351532 PMC: 11439669. DOI: 10.3389/fendo.2024.1468364.

KIT in oocytes: a key factor for oocyte survival and reproductive lifespan.

Luan Y, So W, Dong R, Abazarikia A, Kim S EBioMedicine. 2024; 106:105263.

PMID: 39067135 PMC: 11338130. DOI: 10.1016/j.ebiom.2024.105263.

Healthy eating index and risk of diminished ovarian reserve: a case-control study.

Ghasemi-Tehrani H, Askari G, Allameh F, Vajdi M, Amiri Khosroshahi R, Talebi S Sci Rep. 2024; 14(1):16861.

PMID: 39043733 PMC: 11266691. DOI: 10.1038/s41598-024-67734-y.

Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.

George S, Veludhandi A, Xiang Y, Liu K, Stenger E, Arnold S Transplant Cell Ther. 2024; 30(9):912.e1-912.e13.

PMID: 38972510 PMC: 11344653. DOI: 10.1016/j.jtct.2024.06.029.

References

Sun L, Tan L, Yang F, Luo Y, Li X, Deng H . Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause. 2011; 19(2):126-32. DOI: 10.1097/gme.0b013e318224f9ac. View

Barad D, Weghofer A, Gleicher N . Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009; 91(4 Suppl):1553-5. DOI: 10.1016/j.fertnstert.2008.09.069. View

Hess K . Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995; 14(15):1707-23. DOI: 10.1002/sim.4780141510. View

Scheffer G, Broekmans F, Looman C, Blankenstein M, Fauser B, teJong F . The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod. 2003; 18(4):700-6. DOI: 10.1093/humrep/deg135. View

Gruijters M, Visser J, Durlinger A, Themmen A . Anti-Müllerian hormone and its role in ovarian function. Mol Cell Endocrinol. 2003; 211(1-2):85-90. DOI: 10.1016/j.mce.2003.09.024. View

Hansen K, Hodnett G, Knowlton N, Craig L . Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2010; 95(1):170-5. DOI: 10.1016/j.fertnstert.2010.04.006. View

Sowers M, Eyvazzadeh A, McConnell D, Yosef M, Jannausch M, Zhang D . Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008; 93(9):3478-83. PMC: 2567855. DOI: 10.1210/jc.2008-0567. View

van Asselt K, Kok H, van der Schouw Y, Grobbee D, Te Velde E, Pearson P . Current smoking at menopause rather than duration determines the onset of natural menopause. Epidemiology. 2004; 15(5):634-9. DOI: 10.1097/01.ede.0000134868.53468.b7. View

van Rooij I, Broekmans F, Te Velde E, Fauser B, Bancsi L, de Jong F . Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17(12):3065-71. DOI: 10.1093/humrep/17.12.3065. View

10.

Yang Y, Hur M, Kim S, Young K . Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Menopause. 2011; 18(2):138-45. View

11.

Broer S, Eijkemans M, Scheffer G, van Rooij I, de Vet A, Themmen A . Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011; 96(8):2532-9. DOI: 10.1210/jc.2010-2776. View

12.

Feyereisen E, Lozano D, Taieb J, Hesters L, Frydman R, Fanchin R . Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online. 2006; 12(6):695-703. DOI: 10.1016/s1472-6483(10)61081-4. View

13.

Freeman E, Sammel M, Lin H, Gracia C . Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012; 97(5):1673-80. PMC: 3339896. DOI: 10.1210/jc.2011-3032. View

14.

Freeman E, Sammel M, Gracia C, Kapoor S, Lin H, Liu L . Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril. 2005; 83(2):383-92. DOI: 10.1016/j.fertnstert.2004.06.066. View

15.

de Vet A, Laven J, de Jong F, Themmen A, Fauser B . Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002; 77(2):357-62. DOI: 10.1016/s0015-0282(01)02993-4. View

16.

Jurisicova A, Taniuchi A, Li H, Shang Y, Antenos M, Detmar J . Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. J Clin Invest. 2007; 117(12):3971-8. PMC: 2082141. DOI: 10.1172/JCI28493. View

17.

Fleming L, Levis S, LeBlanc W, Dietz N, Arheart K, Wilkinson J . Earlier age at menopause, work, and tobacco smoke exposure. Menopause. 2008; 15(6):1103-8. PMC: 2703810. DOI: 10.1097/gme.0b013e3181706292. View

18.

Westhoff C, Murphy P, Heller D . Predictors of ovarian follicle number. Fertil Steril. 2000; 74(4):624-8. DOI: 10.1016/s0015-0282(00)01527-2. View

19.

Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50(3):163-70. View

20.

Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F . Predicting age at menopause from serum antimüllerian hormone concentration. Menopause. 2011; 18(7):766-70. DOI: 10.1097/gme.0b013e318205e2ac. View